![](/img/cover-not-exists.png)
High-risk myeloma and minimal residual disease postautologous-HSCT predict worse outcomes
Hu, Bei, Thall, Peter, Milton, Denái R, Sasaki, Koji, Bashir, Qaiser, Shah, Nina, Patel, Krina, Popat, Uday, Hosing, Chitra, Nieto, Yago, Lin, Pei, Delgado, Ruby, Jorgensen, Jeffrey, Manasanch, ElisabLanguage:
english
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2018.1485908
Date:
July, 2018
File:
PDF, 1.32 MB
english, 2018